Banque Pictet & Cie’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-45,415
| Closed | -$4.61M | – | 424 |
|
|
2025
Q4 | $4.61M | Sell |
45,415
-65,104
| -59% | -$5.23M | 0.03% | 155 |
|
|
2025
Q3 | $6.05M | Buy |
110,519
+4
| +0% | +$200 | 0.04% | 134 |
|
|
2025
Q2 | $5.87M | Buy |
110,515
+56,661
| +105% | +$2.88M | 0.04% | 137 |
|
|
2025
Q1 | $2.33M | Sell |
53,854
-16,839
| -24% | -$853K | 0.02% | 200 |
|
|
2024
Q4 | $3.97M | Sell |
70,693
-118,540
| -63% | -$7.38M | 0.03% | 176 |
|
|
2024
Q3 | $12.9M | Buy |
189,233
+6,199
| +3% | +$350K | 0.1% | 78 |
|
|
2024
Q2 | $7.73M | Buy |
183,034
+69,585
| +61% | +$3.83M | 0.07% | 122 |
|
|
2024
Q1 | $7.83M | Sell |
113,449
-77,250
| -41% | -$4.89M | 0.07% | 116 |
|
|
2023
Q4 | $14.1M | Sell |
190,699
-81,942
| -30% | -$5.37M | 0.12% | 74 |
|
|
2023
Q3 | $18.6M | Sell |
272,641
-22,372
| -8% | -$1.9M | 0.22% | 61 |
|
|
2023
Q2 | $27.7M | Buy |
295,013
+2,287
| +0.8% | +$178K | 0.24% | 58 |
|
|
2023
Q1 | $19.8M | Sell |
292,726
-44,020
| -13% | -$2.83M | 0.19% | 63 |
|
|
2022
Q4 | $16.7M | Sell |
336,746
-85,459
| -20% | -$3.49M | 0.17% | 71 |
|
|
2022
Q3 | $13.7M | Sell |
422,205
-1,692
| -0.4% | -$69.8K | 0.15% | 80 |
|
|
2022
Q2 | $16.7K | Sell |
423,897
-66,042
| -13% | -$3.53M | 0.17% | 74 |
|
|
2022
Q1 | $34.3M | Buy |
489,939
+3,040
| +0.6% | +$222K | 0.26% | 49 |
|
|
2021
Q4 | $37.9M | Buy |
486,899
+104,229
| +27% | +$9.2M | 0.28% | 51 |
|
|
2021
Q3 | $36.5M | Sell |
382,670
-12,714
| -3% | -$1.34M | 0.38% | 41 |
|
|
2021
Q2 | $49.1M | Buy |
395,384
+91,495
| +30% | +$10.9M | 0.55% | 29 |
|
|
2021
Q1 | $40M | Buy |
303,889
+80,420
| +36% | +$11M | 0.51% | 33 |
|
|
2020
Q4 | $29.6M | Sell |
223,469
-16,223
| -7% | -$1.96M | 0.4% | 36 |
|
|
2020
Q3 | $24.4M | Buy |
239,692
+19,734
| +9% | +$1.7M | 0.37% | 40 |
|
|
2020
Q2 | $19.1M | Buy |
219,958
+899
| +0.4% | +$71.8K | 0.32% | 43 |
|
|
2020
Q1 | $12.7M | Buy |
219,059
+152,714
| +230% | +$12.4M | 0.26% | 50 |
|
|
2019
Q4 | $6.14M | Buy |
+66,345
| New | +$5.83M | 0.11% | 128 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Banque Pictet & Cie's EXAS Position: Q1 2026 in Review
Banque Pictet & Cie sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 45,415 shares — an estimated $4.61M sold.
Banque Pictet & Cie first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $49.1M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Banque Pictet & Cie reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Banque Pictet & Cie sold 45,415 Exact Sciences shares in Q1 2026, an estimated $4.61M.
- Banque Pictet & Cie first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
- Banque Pictet & Cie's Exact Sciences position peaked at $49.1M in Q2 2021.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.